Finance

Beta
Lists
IMNM:NASDAQ
Immunome Inc
$22.75
-0.13%
(-0.030) 1D
Jul 22, 2:08:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMNM...
Open
$22.58
High
$23.08
Low
$22.48
Mkt. cap
2.58B
Avg. vol.
1.66M
Volume
196.78K
52-wk high
$27.64
52-wk low
$8.66
EPS
-$2.36
Beta
2.07
Shares outstanding
113.25M
No. of employees
206
Open
$22.58
High
$23.08
Low
$22.48
Mkt. cap
2.58B
Avg. vol.
1.66M
Volume
196.78K
52-wk high
$27.64
52-wk low
$8.66
EPS
-$2.36
Beta
2.07
Shares outstanding
113.25M
No. of employees
206
News stories
From sources across the web
About Immunome Inc
CEO-
Employees206
Founded2006
HeadquartersBothell, Washington, United States
SectorBiotechnology
Websiteimmunome.com
Analyst ratings
Based on 14 analysts giving stock ratings to IMNM in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for IMNM in the last 3 months.
Highest
Current $22.75
$40.00 (+75.82%)
Average
$35.36 (+55.43%)
Lowest
$30.00 (+31.87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wedbush
Buy
Maintained
$31.00
+36.3%
07/21/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$40.00
+75.8%
07/20/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
-
-
07/09/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$40.00
+75.8%
07/09/2026
Lukas Shumway
Barclays
Buy
Maintained
$36.00
+58.2%
07/09/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
06/29/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
$36.00
+58.2%
06/11/2026
Chad Messer
Lake Street
Buy
Maintained
$30.00
+31.9%
06/01/2026
Biren Amin
Piper Sandler
Buy
Maintained
$33.00
+45.1%
06/01/2026
Unknown Analyst
Barclays
Buy
Initiated
$36.00
+58.2%
05/28/2026
Andrew Berens
Leerink Partners
Buy
Maintained
$33.00
+45.1%
05/15/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$35.00
+53.8%
05/13/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$40.00
+75.8%
05/13/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$35.00
+53.8%
05/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/12/2026
Karina Rabayeva
Truist Financial
Buy
Maintained
-
-
03/05/2026
Sudan Loganathan
Stephens
Buy
Reiterated
$30.00
+31.9%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.02M
-
-
-
Cost of goods sold
40.45M
49.19M
50.77M
46.38M
Cost of revenue
40.45M
49.19M
50.77M
46.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.04M
10.94M
12.09M
12.95M
Operating expense
10.04M
10.94M
12.09M
12.95M
Total operating expenses
50.49M
60.14M
62.86M
59.33M
Operating income
-46.48M
-60.14M
-62.86M
-59.33M
Other non operating income
-
-
-
-
EBT including unusual items
-43.40M
-57.46M
-69.90M
-53.84M
EBT excluding unusual items
-43.40M
-57.46M
-59.90M
-53.84M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.40M
-57.46M
-69.90M
-53.84M
Net profit margin
-1,080.87%
-
-
-
Earnings per share
-0.50
-0.65
-0.76
-0.48
Interest and investment income
3.08M
2.68M
2.96M
5.49M
Interest expense
-
-
-
-
Net interest expenses
3.08M
2.68M
2.96M
5.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.84M
-59.55M
-62.23M
-58.73M
Gain or loss from assets sale
891.00K
-50.00K
55.00K
79.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer